Literature DB >> 6167662

Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action.

H Y Chen, T Sato, A Fuse, T Kuwata, J Content.   

Abstract

A human endometrial cancer cell line, HEC-1, was found to be resistant to the antiviral and anticellular action of interferon. However, HEC-1 cells were susceptible to the cytotoxicity of natural killer (NK) cells, and interferon enhanced such NK activity. When HEC-1 cells were treated with interferon, sensitivity of HEC cells to the cytotoxicity of NK cells was not suppressed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167662     DOI: 10.1099/0022-1317-52-1-177

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Binding of human interferon alpha to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity.

Authors:  S Yonehara; M Yonehara-Takahashi; A Ishii
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

3.  Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.

Authors:  Jean-Patrick Parisien; Joe F Lau; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 4.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

5.  Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein.

Authors:  Catherine C Cruz; Mehul S Suthar; Stephanie A Montgomery; Reed Shabman; Jason Simmons; Robert E Johnston; Thomas E Morrison; Mark T Heise
Journal:  Virology       Date:  2010-01-25       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.